BCOR and sarcoma: While outcomes in patients with BCOR-altered sarcoma are comparable with those in Ewing sarcoma, survival with CIC-rearranged sarcoma is poor irrespective of chemotherapy; use of soft tissue sarcoma regimens such doxorubicin and ifosfamide have similar outcomes for those with localised disease.